These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 12776266

  • 1. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
    Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M, West Japan Cooperative Study Group of Kidney Disease in Children.
    Am J Kidney Dis; 2003 Jun; 41(6):1155-62. PubMed ID: 12776266
    [Abstract] [Full Text] [Related]

  • 2. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
    Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M.
    Kidney Int; 2000 Sep; 58(3):1247-52. PubMed ID: 10972687
    [Abstract] [Full Text] [Related]

  • 3. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.
    Ueda N, Chihara M, Kawaguchi S, Niinomi Y, Nonoda T, Matsumoto J, Ohnishi M, Yasaki T.
    J Pediatr; 1988 Jan; 112(1):122-6. PubMed ID: 3335948
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
    Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
    [Abstract] [Full Text] [Related]

  • 5. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK, Bagga A, Srivastava RN.
    Pediatr Nephrol; 1997 Oct; 11(5):597-9. PubMed ID: 9323286
    [Abstract] [Full Text] [Related]

  • 6. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
    Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
    Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.
    Basu B, Bhattacharyya S, Barua S, Naskar A, Roy B.
    Clin Exp Nephrol; 2020 Jul 08; 24(7):622-629. PubMed ID: 32201918
    [Abstract] [Full Text] [Related]

  • 8. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K, Parikh A, Webb H, Hothi D.
    Pediatr Nephrol; 2017 Jan 08; 32(1):99-105. PubMed ID: 27677978
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome.
    Cerkauskiene R, Kaltenis P.
    Medicina (Kaunas); 2005 Jan 08; 41 Suppl 1():26-30. PubMed ID: 15901972
    [Abstract] [Full Text] [Related]

  • 10. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
    Pediatr Nephrol; 2017 Aug 08; 32(8):1377-1382. PubMed ID: 28341877
    [Abstract] [Full Text] [Related]

  • 11. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
    Raman V, Krishnamurthy S, Harichandrakumar KT.
    Pediatr Nephrol; 2016 Apr 08; 31(4):595-604. PubMed ID: 26759000
    [Abstract] [Full Text] [Related]

  • 12. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Lancet; 1988 Feb 20; 1(8582):380-3. PubMed ID: 2893190
    [Abstract] [Full Text] [Related]

  • 13. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
    Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
    Mymensingh Med J; 2014 Apr 20; 23(2):261-7. PubMed ID: 24858152
    [Abstract] [Full Text] [Related]

  • 14. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
    Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
    Clin Exp Nephrol; 2017 Aug 20; 21(4):671-676. PubMed ID: 27558467
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul 20; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 16. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
    Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
    Arch Dis Child; 2007 Jul 20; 92(7):585-8. PubMed ID: 17284479
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A, Hari P, Moudgil A, Jordan SC.
    Am J Kidney Dis; 2003 Dec 20; 42(6):1114-20. PubMed ID: 14655181
    [Abstract] [Full Text] [Related]

  • 18. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
    Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
    BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
    [Abstract] [Full Text] [Related]

  • 19. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
    Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S.
    Nihon Jinzo Gakkai Shi; 2010 May 23; 52(8):1029-36. PubMed ID: 21254699
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2001 May 23; (2):CD001533. PubMed ID: 11405997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.